We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Deep Sequencing Study Reveals New Insights into Human Transcriptome

By Biotechdaily staff writers
Posted on 05 Aug 2008
A new joint project is taking the first step towards a new depiction of the mammalian genome annotation.

In a collaborative project, scientists from the Max-Planck-Institute for Molecular Genetics (MPI MolGen; Berlin, Germany) and Genomatix Software (Munich, Germany and Ann Arbor, MI, USA) applied next-generation sequencing and analysis techniques to generate an unprecedented view at the human transcriptome.

Deep sequencing of transcripts from two human cell lines revealed so far unrecognized complexity and variability of the human transcriptome. They found that 34% of the polyadenylated transcriptome mapped to so far non-annotated genomic regions. Obviously, a large number of novel gene candidates are active in the cell lines under examination. In addition, a global survey of mRNA splicing events identified 94,241 splice junctions, of which 4,096 are novel, and showed that exon skipping is the most prevalent form of alternative splicing.

Details were published by Dr. P. K. Sultan and colleagues online in July 2008, at Science Express.

Dr. Marie-Laure Yaspo, group leader at the MPI MolGen and head scientist of the study stated, "Deep sequencing allows for the first time to explore directly the complexity and dynamics of the human transcriptome with a reasonable effort. This will lead to a new picture of the mammalian genome annotation far beyond the current state of the art. We provide here global features of alternative splicing events in human cell lines. Such a comparison of within-cell and between-cell alternative splicing events, combined with the simultaneous analysis of gene expression has never been presented before. It becomes clear that the so far available methods only delivered a part of the transcriptional landscape of mammalian cells, especially if gene regulation analysis is considered.”

Dr. Martin Seifert, vice president business development and consulting at Genomatix stated, "The main biological impact is the observation of a new dimension in complexity and variability. Based on the method we could find a significant number of new transcriptional units and splice variants. Our analyses clearly show that transcription is a highly dynamic and variable process. We learned a lot by having access to such high quality data and co-developed necessary new analysis strategies with the MPI MolGen. Especially users of our brand new Genomatix genome analyzer will benefit from our experiences along the project, since they have access to all developed strategies.”


Related Links:
Annotation and data visualization
Max-Planck-Institute for Molecular Genetics
Genomatix Software

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
HPV Molecular Test
BD Onclarity HPV Assay

Latest BioResearch News

Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
05 Aug 2008  |   BioResearch

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
05 Aug 2008  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
05 Aug 2008  |   BioResearch